359,777 Cigna Group $CI Shares Acquired by Boston Partners

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Boston Partners increased its Cigna stake by 17.9% in the third quarter, buying 359,777 shares and bringing its holdings to about 2.37 million shares, valued at $645.5 million.
  • Cigna beat quarterly expectations, reporting adjusted EPS of $7.98 versus $7.52 forecast and revenue of $73.79 billion; revenue rose 5.6% year over year.
  • Analysts’ consensus rating is Moderate Buy, with an average price target of $336.90. Cigna also announced a quarterly dividend of $1.56 per share, equal to a 2.2% yield.
  • MarketBeat previews the top five stocks to own by December 1st.

Boston Partners boosted its position in Cigna Group (NYSE:CI - Free Report) by 17.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 2,374,437 shares of the health services provider's stock after purchasing an additional 359,777 shares during the period. Boston Partners owned about 0.90% of Cigna Group worth $645,467,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Osbon Capital Management LLC purchased a new position in shares of Cigna Group in the 2nd quarter worth approximately $26,000. Putney Financial Group LLC bought a new position in shares of Cigna Group in the third quarter valued at approximately $27,000. Johnson Financial Group Inc. bought a new position in shares of Cigna Group in the second quarter valued at approximately $29,000. Fiduciary Financial Advisors purchased a new stake in shares of Cigna Group during the second quarter valued at approximately $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new stake in shares of Cigna Group during the second quarter valued at approximately $34,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Insiders Place Their Bets

In other Cigna Group news, insider Everett Neville sold 617 shares of the firm's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company's stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company's stock.

Cigna Group Stock Down 3.2%

Cigna Group stock opened at $284.67 on Thursday. Cigna Group has a twelve month low of $257.85 and a twelve month high of $318.05. The firm has a 50 day moving average price of $288.37 and a 200-day moving average price of $283.00. The company has a market capitalization of $75.01 billion, a P/E ratio of 12.56, a P/E/G ratio of 1.10 and a beta of 0.25. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.52 by $0.46. The company had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. Cigna Group's quarterly revenue was up 5.6% compared to the same quarter last year. During the same quarter last year, the business posted $7.83 EPS. As a group, equities analysts predict that Cigna Group will post 30.71 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 3rd. Cigna Group's dividend payout ratio is 27.54%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on CI shares. Guggenheim dropped their price target on Cigna Group from $361.00 to $347.00 and set a "buy" rating on the stock in a report on Friday, November 6th. Royal Bank Of Canada restated an "outperform" rating and issued a $337.00 price objective on shares of Cigna Group in a research note on Thursday, October 1st. Wall Street Zen raised Cigna Group from a "hold" rating to a "buy" rating in a research report on Sunday, November 8th. Piper Sandler lowered their target price on Cigna Group from $370.00 to $360.00 and set an "overweight" rating on the stock in a research note on Thursday, November 12th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $340.00 target price on shares of Cigna Group in a research note on Friday, November 6th. Fourteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Cigna Group presently has a consensus rating of "Moderate Buy" and an average price target of $336.90.

Get Our Latest Report on CI

Cigna Group Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines